ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,564.41
1.08%
US Tech 100
19,274.40
1.39%
Dow Jones
40,421.36
0.33%
Brent Oil
81.545
-0.89%
Bitcoin
67,932.06
-0.33%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Dyne Therapeutics Inc (DYN) Quote

Dyne Therapeutics Inc

Dyne Therapeutics Inc (DYN)

NASDAQ
43.19
1.72
(4.15%)
At close: July 22 4:00PM
Delayed by 15 minutes
43.19
0.02
( 0.05% )
After Hours: 4:01PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
43.19
Bid
42.35
Ask
44.03
Volume
796,647
41.36 Day's Range 43.47
6.40 52 Week Range 44.33
Market Cap
3.624B
Previous Close
41.47
Open
41.63
Last Trade
10881
@
43.19
(priorref)
Last Trade Time
16:10:56
Financial Volume
$ 33,662,323
VWAP
42.255
Average Volume (3m)
1,212,941
Shares Outstanding
87,382,638
Dividend Yield
-
PE Ratio
-15.99
Earnings Per Share (EPS)
-2.7
Revenue
-
Net Profit
-235.94M

About Dyne Therapeutics Inc

Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. Dyne Therapeutics Inc is a bio-technology company focused on providing therapeutics for patients with genetically driven diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.dyne-tx.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Dyne Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker DYN. The last closing price for Dyne Therapeutics was $41.47. Over the last year, Dyne Therapeutics shares have traded in a share price range of $ 6.40 to $ 44.33.

Dyne Therapeutics currently has 87,382,638 shares outstanding. The market capitalization of Dyne Therapeutics is $3.62 billion. Dyne Therapeutics has a price to earnings ratio (PE ratio) of -15.99.

DYN Latest News

More News

Dyne Therapeutics Presents New Preclinical Data Demonstrating the Potential of the FORCE™ Platform to Deliver Enzyme Replacement Therapy to Muscle and CNS in Pompe Disease

WALTHAM, Mass., June 24, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics...

June 24 2024
GlobeNewswire Inc.

Dyne Therapeutics Presents New Preclinical Data for its Facioscapulohumeral Muscular Dystrophy Program During the FSHD Society International Research Congress

- Leveraging the FORCE™ Platform, DYNE-302 Achieved Robust and Durable DUX4 Suppression and Functional Benefit in FSHD Preclinical Models - WALTHAM, Mass., June 13, 2024 (GLOBE NEWSWIRE...

June 13 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

June 11 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

June 11 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

June 11 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

June 11 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

June 11 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

June 11 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.974.7792333818541.2244.3340.7896091542.5240781CS
47.922.385945026935.2944.3332.7893126038.44281797CS
1218.5275.0709363624.6744.3324.67121294132.8877582CS
2627.58176.6816143515.6144.3315.59129633728.27782609CS
5232.33297.69797421710.8644.336.4115440021.80256281CS
15623.71121.71457905519.4844.334.357335918.47251953CS
26019.7484.179104477623.4544.334.351718518.61632778CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LIFWMSP Recovery Inc
$ 0.86
(69.73%)
9.44M
TUSKMammoth Energy Services Inc
$ 4.75
(35.71%)
147.77k
FEIMFrequency Electronics Inc
$ 13.10
(29.70%)
64.52k
LGHLWLion Group Holding Ltd
$ 0.0088
(23.94%)
300
LUXHLuxUrban Hotels Inc
$ 0.1653
(12.22%)
2.82M
AAGRAfrican Agriculture Holdings Inc
$ 0.163
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 62.8042
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.53
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.39
(0.00%)
0
AACGATA Creativity Global
$ 0.65
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.163
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 62.8042
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.53
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.39
(0.00%)
0
AACGATA Creativity Global
$ 0.65
(0.00%)
0

Discussion

View Full Feed
slops slops 5 minutes ago
Fdc4 At least you can see the big picture
VDRM
skitahoe skitahoe 5 minutes ago
RD, I'm still hoping for 2025 and believe that the EDEN can be approved by the end of the first half of that year. If I'm right about that, and if NWBO is working on everything else needed to submit to all the regulators, I think it's possible for some, if not all, approvals by the end of 2025.
NWBO
loanshark007 loanshark007 5 minutes ago
Those figures are a bunch of arbitrary BS. That's not how it works.
GRST
Seriously123 Seriously123 6 minutes ago
Trump bro...

Go Trump

We will be out of UNESCO (again)
SFRX
thistraderknowsall thistraderknowsall 6 minutes ago
SUKU Altcoin.... Surges back to $1.50 today..Prepandemic!GREAT NEWS!!! Congrats!!
barnyarddog barnyarddog 6 minutes ago
Newbury Street Acquisition Corporation (Nasdaq: NBST) (“Newbury” or the “Company”), received notice from the Nasdaq Office of General Counsel that the Nasdaq Hearings Panel (the “Panel”) had granted the Company’s request to continue its listing on Nasdaq through September 23, 2024 (the “Extended Dat
NBST
barnyarddog barnyarddog 7 minutes ago
Jul-09-24 09:00AM Infinite Reality Closes $350 Million Investment; Acquires Landvault in $450 Million Deal, Valuation Soars to $5.1 Billion (GlobeNewswire)

Jun-12-24 04:08PM Infinite Reality's SPAC Partner, Newbury Street Acquisition Corp., Announces Nasdaq Extension for Proposed Bu
NBST
stock1ace1 stock1ace1 7 minutes ago
News ????
Mr. C Mr. C 8 minutes ago
The company’s business is political and its future is dependent on the election. Please police another board
TGLO
stock1ace1 stock1ace1 8 minutes ago
NCNA $3.18 -> Pt raised from $4 to $150 !!

NuCana Is Maintained at Outperform by Oppenheimer

The high is $150 issued by Oppenheimer on July 22, 2024

https://www.benzinga.com/quote/NCNA/analyst-ratings
NCNA
Ribo Ribo 8 minutes ago
Name/Symbol Changes & RS
https://acrobat.adobe.com/id/urn:aaid:sc:VA6C2:68d79cbb-910f-47d4-af87-2d3410601a8a

The RS is tied in with the Name/Symbol Change.

Once the Name/Symbol Change is executed the RS will follow.
CGAC
mc73 mc73 8 minutes ago
💯
RDGL
BigBadWolf BigBadWolf 8 minutes ago
btw GRLT releases the same old news (to a wider audience shall we say) while still NOT submitting the Attorney Letter. Just in case any have not calculated come 7/31/24 the Yield Sign will be further downgraded as their 4 month allowance to submit will have passed. I have spoken w/ OTC, feel free
GRLT
Squirrely_McShitty Squirrely_McShitty 8 minutes ago
I want this to happen as much or more than everyone, but I will bet any takers that it won't happen by Friday 8:00 pm Eastern. For street cred.
CNNA
art2426 art2426 9 minutes ago
Yep, it looks like that 911 trade at the end of Friday that so many got excited about, was a 'false alarm'.
BIEL
getmoreshares getmoreshares 9 minutes ago
agree-- check the history-- no or very little vol in YEARS
AIKO
Lurker3 Lurker3 9 minutes ago
And after each roth conference, benzinga interview, conference. When lebby ipens his mouth the investment community sells the stock.
LWLG
ALDRADJKD123 ALDRADJKD123 9 minutes ago
“They” are part of the everybody must play and everybody gets a trophy crowd…
Nemesis18 Nemesis18 9 minutes ago
>>> Senti,
It's not mistaken. It is definitive.
NWBO
wrenchit wrenchit 9 minutes ago
Just to clarify when I meet with Rhonda setting up a location to carry product she did state to me she was working for APRU and why did she get 10 mil shares for services rendered part of Salary negotiations. yes i will be reaching out to Tony hopefully he responds to my email or answers my call we
APRU
Paulie Cashews Paulie Cashews 10 minutes ago
I put my name into IHUB Ai, and it certainly described me perfectly:

Paulie Cashews is a beloved figure on IHUB, renowned for his wit and comedic flair that injects a lively spirit into the community. As a prominent member and frequent poster, Paulie's humorous cartoons and images tra
Yooperman Yooperman 10 minutes ago
Definitely a quiet day.
TSOI
IH Admin [Shelly] IH Admin [Shelly] 10 minutes ago
You all can take your political commentary to one of those boards. This one is to talk about the company/stock TGLO
TGLO

Your Recent History

NASDAQ
DYN
Dyne Therapeutics
BITMOT
899320
A2a Slb Tf 0,625% Lg31 C...
TG
CHSA
UBS Global Asset Managem...
NASDAQ
ABGDFXX
Royal Bank of Canada Poi...
TG
ZPAB
Amndi S&P Euzn PAB Net Z...
LSE
LLOY
Lloyds Banking
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved